← Back

Wire · technology

AI-Powered Biology: Building the Next Generation of Genomics & Therapeutics

Published

3 August 2026

Topic

technology

Sectors

AI InfrastructureBiotechDrug Discovery

Source

Read at nebius.com

Verified

Fusion42 · 3 August 2026 · Fusion42 review

NVIDIA and Nebius are hosting a workshop on the BioNeMo Agent Toolkit, a platform that helps life sciences teams build AI-powered workflows to accelerate genomics research, drug discovery, and computational biology.

This Wire brief sits within Fusion42's coverage of AI Infrastructure, Biotech and Drug Discovery. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.

◆ The Wire takeaway

You can now build AI workflows tailored for biotech using NVIDIA's agent platform, opening a new route to cut research time and cost in genomics and drug discovery.

Related on Wire

Topics

AI InfrastructureBiotechDrug Discoveryaibiotechdrug-discoverygenomicslife-sciences